ArticleInternational journal of general medicine2026
Tumor-Restricted CXCR4 and MIF Signaling Axis is Associated with T Cell-Mediated Macrophage Exclusion in Gastrointestinal Stromal Tumors.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Gastrointestinal stromal tumors (GISTs), driven by KIT/PDGFRA mutations and treated with tyrosine kinase inhibitors (TKIs), remain challenged by drug resistance, suggesting that poorly understood mechanisms sustain an immunosuppressive tumor microenvironment (TME). This study aimed to investigate the cellular and molecular basis of the immune architecture in GISTs through integrated multi-omics analysis. Patients and Methods: We integrated bulk RNA-sequencing data from 20 GISTs and 20 matched normal tissue samples (GSE225819) with single-cell RNA-sequencing data from 2 GISTs and 2 normal tissue samples (GSE162115) to dissect the cellular and molecular basis of TME. Weighted gene co-expression network analysis (WGCNA), immune deconvolution (CIBERSORTx), cell-cell communication inference (CellChat), and pseudotime trajectory analysis (Monocle 3) were employed. In vitro functional validation was performed using the GIST-T1 cell line, and clinical specimens were analyzed by RT-qPCR and flow cytometry. Results: Transcriptomic profiling of GISTs revealed an inverse correlation between activated T-cell signatures and macrophage abundance, alongside significant transcriptional remodeling (1071 upregulated and 1211 downregulated genes). scRNA-seq further identified a tumor cell subpopulation with high C-X-C Motif Chemokine Receptor 4 (CXCR4) expression that, together with activated CD4⁺ memory T cells, produced macrophage migration inhibitory factor (MIF). Ligand-receptor analysis identified the MIF pathway as the dominant intercellular signaling network, primarily targeting macrophages, thereby offering a mechanistic basis for their reduced presence in the TME. In vitro, CXCR4 knockdown suppressed MIF mRNA expression and cell proliferation. In clinical specimens, tumor tissue CXCR4 and MIF transcripts were elevated and positively correlated with T-cell-derived MIF protein, which inversely correlated with macrophage infiltration. Conclusion: Our study identifies a CXCR4⁺ GISTs tumor subpopulation associated with CD4⁺ T cell activation and MIF signaling amplification, which correlates with reduced macrophage infiltration. These findings nominate the CXCR4/MIF axis as a candidate therapeutic target, although further functional validation is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.